The 'Ozempic Effect': Reshaping Consumer Spending.
Consumer spendingHealthcare trendsMarket AnalysisOzempicRetail impact
The report explores how GLP-1 drugs, such as Ozempic, are reshaping consumer spending in food, retail, and leisure sectors across North America. It examines shifts in consumer behavior as more people adopt these treatments, causing dietary preferences and lifestyle choices to change. The analysis delves into how industries are responding with new products and services to meet evolving consumer demands. It provides strategic insights for investors, highlighting opportunities in health-oriented brands and sectors showing innovation due to these consumer changes.
Unnatti Jaiswal, Ghost Research
January 2026
Perspective.
PurposeTo analyze the impact of GLP-1 drugs on consumer spending across food, retail, and leisure sectors.
AudienceInvestors, industry experts, and market analysts.
Special EmphasisInnovation, investment strategies.
57Pages of Deep Analysis
166Curated Credible Sources
10Proprietary AI Visuals
14Data Analysis Tables
$495
Unnatti Jaiswal
4+ Years of Experience
Sectors & Industries
IndustrialsInformation Technology
Functions & Expertise
Market IntelligenceConsumer & Retail
Have questions? Our Research Desk is here to help
Top Insights.
GLP-1 drugs are changing dietary and spending habits significantly.Investors should focus on health-oriented brands as consumer preferences shift.The pharmaceutical market for GLP-1 therapies is projected to grow substantially.Apparel and fashion industries are adapting to changing size demands.Insurance and healthcare policies are evolving to accommodate GLP-1 use.Key Questions Answered.
57Pages of Deep Analysis
10Proprietary AI Visuals
166Curated Credible Sources
14Data Analysis Tables
Summary.
